2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide

C36H42BrN5O5 — CID 18657993

IUPAC2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide
SMILESCCNC(=O)c1ccccc1-c1[nH]c2ccc(CN3C(=O)[C@H](NC(=O)CC(C)(C)NC[C@H](O)CO)CCc4ccccc43)cc2c1Br
InChIInChI=1S/C36H42BrN5O5/c1-4-38-34(46)26-11-7-6-10-25(26)33-32(37)27-17-22(13-15-28(27)41-33)20-42-30-12-8-5-9-23(30)14-16-29(35(42)47)40-31(45)18-36(2,3)39-19-24(44)21-43/h5-13,15,17,24,29,39,41,43-44H,4,14,16,18-21H2,1-3H3,(H,38,46)(H,40,45)/t24-,29+/m0/s1
InChIKeyNYJXRCPCDQBVNG-PWUYWRBVSA-N
MW704.67 g/mol
LogP4.42
Rot. Bonds12

About 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide

2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide (PubChem CID 18657993) has the molecular formula C36H42BrN5O5 and a molecular weight of 704.67 g/mol. Its IUPAC name is 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide.

Molecular Properties

Compound Name2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide
PubChem CID18657993
Molecular FormulaC36H42BrN5O5
Molecular Weight704.67 g/mol
Exact Mass703.24
IUPAC Name2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide
SMILESCCNC(=O)c1ccccc1-c1[nH]c2ccc(CN3C(=O)[C@H](NC(=O)CC(C)(C)NC[C@H](O)CO)CCc4ccccc43)cc2c1Br
InChIInChI=1S/C36H42BrN5O5/c1-4-38-34(46)26-11-7-6-10-25(26)33-32(37)27-17-22(13-15-28(27)41-33)20-42-30-12-8-5-9-23(30)14-16-29(35(42)47)40-31(45)18-36(2,3)39-19-24(44)21-43/h5-13,15,17,24,29,39,41,43-44H,4,14,16,18-21H2,1-3H3,(H,38,46)(H,40,45)/t24-,29+/m0/s1
InChIKeyNYJXRCPCDQBVNG-PWUYWRBVSA-N
XLogP4.42
TPSA146.79 Ų
H-Bond Donors6
H-Bond Acceptors6
Rotatable Bonds12
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500704.67
LogP ≤ 54.42
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 106

Analyze 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide?
The IUPAC name of 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide (CID 18657993) is 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide.
What is the SMILES notation for 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide?
The canonical SMILES for 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide is CCNC(=O)c1ccccc1-c1[nH]c2ccc(CN3C(=O)[C@H](NC(=O)CC(C)(C)NC[C@H](O)CO)CCc4ccccc43)cc2c1Br.
What is the InChIKey of 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide?
The InChIKey is NYJXRCPCDQBVNG-PWUYWRBVSA-N. The full InChI is InChI=1S/C36H42BrN5O5/c1-4-38-34(46)26-11-7-6-10-25(26)33-32(37)27-17-22(13-15-28(27)41-33)20-42-30-12-8-5-9-23(30)14-16-29(35(42)47)40-31(45)18-36(2,3)39-19-24(44)21-43/h5-13,15,17,24,29,39,41,43-44H,4,14,16,18-21H2,1-3H3,(H,38,46)(H,40,45)/t24-,29+/m0/s1.
What are the key properties of 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide?
2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide has a molecular weight of 704.67 g/mol, XLogP of 4.42, 12 rotatable bonds, 6 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-bromo-5-[[(3R)-3-[[3-[[(2S)-2,3-dihydroxypropyl]amino]-3-methylbutanoyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]methyl]-1H-indol-2-yl]-N-ethylbenzamide is sourced from PubChem (CID 18657993), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).